
    
      This study is a multi-center, placebo-controlled, randomized trial comparing acupuncture and
      placebo needle among patients with CP/CPPS, which will be conducted in Guang'anmen Hospital
      of China Academy of Chinese Medical Sciences and Yantai Chinese Medicine Hospital from
      November 2015 to May 2017. 68 patients will be recruited in total through the advertisements
      spreading by newspaper, television and internet. After participants have completed a baseline
      evaluation and meet the selection criteria, one professional statistician uninvolved with
      treatment and data collection will assigns the participants by using a computer generated,
      blocked random allocation sequence randomly and acupuncturist will be blinded to the process
      of randomized assignment.Treatment group will use acupuncture and control group will use
      placebo needle, for treatment, Zhongliao (BL 33), Shenshu (BL 23), Guiyang (BL 35),
      Sanyinjiao (SP 6) acupuncture points will be used, the treatment sessions are 24 weeks after
      baseline, 3 times a week and each time the patients will accept a 30 minutes treatment, to
      control group, participants will receive placebo needle treatment at the same acupuncture
      points and the duration and frequency of sessions are same to the real acupuncture group. The
      primary outcome measure of this study is the decreasing in (National Institutes of Health
      Chronic Prostatitis Symptom Index) NIH-CPSI total score from baseline to week 8, and
      secondary outcomes include NIH-CPSI sub scales at week, (International Prostate Symptom
      Score) IPSS total score, Global response assessment, expectation degree and satisfaction
      degree. The first three secondary outcomes will be measured at 4,8,20 and 32 weeks,
      expectation degree will be measured at baseline, and the satisfaction degree will be measure
      at 8, 20, 32 weeks.
    
  